Breast

27 registered clinical trials studyying Breast — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Effect of Topical Oxygen and LED Light Therapy on Nipple Crack NCT07370051	Istanbul University - Cerrahpasa	N/A
Recruiting	Clinical Translation Research on a Multi-omics Breast Cancer Distant Metastasis Prediction Model Empowered by NCT07252986	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Recruiting	A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy NCT06382272	University of Chicago	N/A
Enrolling By Invitation	A Multicenter Prospective Cohort Study of Adjuvant Therapy for BRCA1/2 Mutated Hormone Receptor-positive HER2- NCT06791161	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	—
Completed	Measuring Electrical Properties of Breast Tissues NCT06157879	University of Calgary	N/A
Terminated	A Study to Evaluate the Efficacy and Toxicities of PLX038, in Patients With Locally Advanced or Metastatic Tri NCT06162351	Institut Curie	Phase 2
Recruiting	Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context NCT06083415	Lille Catholic University	N/A
Active Not Recruiting	Robotic vs. Open NSM for Early Stage Breast Cancer NCT05720039	Intuitive Surgical	N/A
Completed	Magnesium Sulphate Versus Ketamine as an Adjuvant to Bupivacaine in Pectoral Nerve Block During Mastectomy NCT05663801	Beni-Suef University	Phase 2
Completed	Development of an Application-Based Digital Navigator for Perioperative Breast Surgery Patients NCT05290402	M.D. Anderson Cancer Center	—
Completed	A Study of High-Dose Vit D Versus Standard of Care Vit D Supplementation NCT05016310	Wake Forest University Health Sciences	N/A
Recruiting	A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Sing NCT04333706	University of Southern California	Phase 1 / Phase 2
Terminated	Breast Arterial Calcifications as an Imaging Biomarker of Cardiovascular Risk NCT07156006	IRCCS Policlinico S. Donato	—
Recruiting	Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer NCT04174742	Wake Forest University Health Sciences	—
Completed	Case Collection Study to Determine the Accuracy, Call Back and Cancer Detection Rates of QT Ultrasound in Brea NCT03052166	QT Ultrasound LLC	—
Unknown	Detection of Breast Lesions by Automatic Breast US NCT03047122	Assuta Medical Center	—
Completed	Patterns of Treatment and Outcome of Palbociclib Plus Endocrine Therapy NCT04524728	Istituti Clinici Scientifici Maugeri SpA	—
Active Not Recruiting	A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors. NCT02734004	AstraZeneca	Phase 1 / Phase 2
Completed	Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats NCT01078662	AstraZeneca	Phase 2
Withdrawn	Post-Breast Procedure Pain Syndrome Study NCT01114984	Cedars-Sinai Medical Center	—
Withdrawn	Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer NCT00845078	University of Pittsburgh	—
Completed	Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors NCT00972205	National Cancer Institute (NCI)	N/A
Active Not Recruiting	Options on the Breast Reconstruction Timing and Method After Removal of Polyacrylamide Hydrogel NCT04715802	First Affiliated Hospital of Zhejiang University	—
Completed	Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors NCT00064857	National Center for Complementary and Integrative Health (NCCIH)	Phase 2
Completed	Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols NCT00026689	National Cancer Institute (NCI)	—
Completed	Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer NCT00277069	University of New Mexico	Phase 1 / Phase 2
Terminated	Physiological Biomarkers of Cancer Treatment Related Fatigue in Women With Breast Cancer. NCT00277004	University of New Mexico	—